The 17th European Congress: Perspectives in Lung Cancer, held from 4-5 March 2016 in Prague, provided attendees with valuable information regarding new treatment algorithms, targeted drugs, diagnostics, strategies for better use of chemotherapy, and key clinical trials data for the management of patients with lung cancer.
Knowing the most-up-to-date techniques and data for developing strategies to personalize therapies for your patients is essential for best practices. A significant amount of practice changing data that affects the optimal way to treat, manage and care for your patients with lung cancer has been presented recently. Guided by world-renowned lung cancer experts, Perspectives in Lung Cancer not only provided a comprehensive overview of the most significant advances in lung cancer treatment, but aided physicians by confirming their current practices and optimizing their patient care.
In this presentation, Dr. David Waller argues that surgery is the treatment of choice for Stage 1 non-small cell lung cancer (NSCLC).
A continuing education program is offered as a supplement to this webcast at the following location:
[ Ссылка ]
© 2016 Imedex, LLC.
